| Date Filed | Type | Description |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| Prange Karen (Director) has filed a Form 4 on AtriCure, Inc.|
Txns:
| Sold 713 shares
@ $47.89, valued at
$34.1k
|
|
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/30/2023 |
4
| Prange Karen (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 05/26/2023 |
4
| Prange Karen (Director) has filed a Form 4 on AtriCure, Inc.|
Txns:
| Granted 3,186 shares
@ $0 |
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Prange Karen (Director) has filed a Form 4 on ViewRay, Inc.|
Txns:
| Granted 54,511 shares
@ $0 |
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Prange Karen (Director) has filed a Form 4 on Embecta Corp.|
Txns:
| Granted 6,024 shares
@ $0 |
|
| 04/05/2022 |
3
| Prange Karen (Director) has filed a Form 3 on Embecta Corp. |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Prange Karen (Director) has filed a Form 4 on AtriCure, Inc.|
Txns:
| Granted 2,452 shares
@ $0 |
|
| 12/18/2019 |
4
| Prange Karen (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 2,703 shares
@ $0 |
|
| 12/18/2019 |
3
| Prange Karen (Director) has filed a Form 3 on NEVRO CORP |
| 12/05/2019 |
4
| Prange Karen (Director) has filed a Form 4 on AtriCure, Inc.|
Txns:
| Granted 5,902 shares
@ $0 |
|
| 12/04/2019 |
3
| Prange Karen (Director) has filed a Form 3 on AtriCure, Inc. |
| 10/29/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/06/2018 |
4
| Prange Karen (EVP&CEO Gl.AH.Med.Den.Sur.Grp) has filed a Form 4 on HENRY SCHEIN INC|
Txns:
| Granted 19,558 shares
@ $0 |
|
| 03/08/2017 |
4
| Prange Karen (EVP&CEO Gl.AH.Med.Den.Sur.Grp) has filed a Form 4 on HENRY SCHEIN INC|
Txns:
| Granted 8,777 shares
@ $0 |
|
| 06/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2013 |
4
| Prange Karen (SVP&Pres, Uro & Women's Health) has filed a Form 4 on BOSTON SCIENTIFIC CORP|
Txns:
| Granted 18,606 restricted stock units
@ $0
Granted 48,439 options to buy
@ $7.39, valued at
$358k
|
|